Cover: Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices

Use of Real-World Evidence for Regulatory Approval and Coverage of Medical Devices

A Landscape Assessment

Published in: Value in Health (2021). doi: 10.1016/j.jval.2021.07.003

Posted on rand.org Nov 3, 2021

by Justin W. Timbie, Alice Y. Kim, Thomas W. Concannon

Real-world evidence (RWE) (as opposed to evidence from clinical trials) is an underutilized resource to support FDA processes and pharmaceutical regulations. Stakeholder interviews suggested the RWE has a role to play, but there are concerns about its rigor.

Research conducted by

This report is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.